Maastricht University is a public research university in Maastricht, Netherlands. Founded in 1976, it is the second youngest of the thirteen Dutch universities. In 2020, 21,085 students studied at Maastricht University, 55% of whom were foreign students, with over 4,000 employees.

During the past decade, Maastricht University conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 3 clinical trials were completed, i.e. on average, 3% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 3 clinical trials were completed. i.e. 5.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maastricht University" #1 sponsor was "Maastricht University Medical Center" with 87 trials, followed by "Maastricht University" with 49 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Anne Birgitte Raben" with 2 trials sponsored and "Jazz Pharmaceuticals" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maastricht University" #1 collaborator was "Maastricht University" with 12 trials as a collaborator, "Top Institute Food and Nutrition" with 11 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 9 trials as a collaborator, "Netherlands Organisation for Scientific Research" with 4 trials as a collaborator and "Maastricht University Medical Center" with 3 trials as a collaborator. Other collaborators include 114 different institutions and companies that were collaborators in the rest 107 trials.

According to Clinical.Site data, the most researched conditions in "Maastricht University" are "Obesity" (19 trials), "Insulin Resistance" (12 trials), "Diabetes Mellitus, Type 2" (8 trials), "Healthy" (7 trials) and "Sarcopenia" (7 trials). Many other conditions were trialed in "Maastricht University" in a lesser frequency.

Most popular intervention types in "Maastricht University" are "Dietary Supplement" (56 trials), "Other" (50 trials), "Behavioral" (25 trials), "Drug" (21 trials) and "Device" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "placebo" (4 trials), "Control" (3 trials), "NaCl" (3 trials) and "Cold exposure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maastricht University" are 122 trials for "All" genders, 39 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are 33 active trials in "Maastricht University". 3 are not yet recruiting, 27 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 112 completed trials in Maastricht University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Maastricht University, 7 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 119 trials that are defined as “Not Applicable".

Maastricht University has several departments that took part in Clinical trials: "Maastricht Radiation Oncology" - 18 trials, "Department of Human Biology, Maastricht University Medical Centre" - 5 trials, "Maastricht University, Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht (NUTRIM)" - 2 trials, "Department of Surgery; Maastricht University Medical Centre" - 2 trials, "Maastricht University Medical Center, Division of Gastroenterology/Hepatology" - 2 trials